Genentech, Inc. H-1B Visa Sponsorship

South San Francisco, California · Professional Services
32
Total Filings
90.6%
Approval Rate
0
Denied
$126,942
Median Salary

Top Sponsored Job Titles

Molecular and Cellular Biologists 5 filings
Bioinformatics Scientists 4 filings
Medical Scientists, Except Epidemiologists 3 filings
Industrial Engineers 3 filings
Information Security Analysts 2 filings

Salary Breakdown

$116,376 Median: $126,942 $161,637
25th Percentile 75th Percentile

Based on 32 salary records from H-1B filings. Figures represent base salary only and do not include stock options, bonuses, or other compensation.

What This Means for You

Genentech, Inc. is a reliable H-1B sponsor with a 90.6% approval rate, suggesting well-established immigration processes. The median salary of $126,942 for sponsored roles is competitive and above the national average. With 32 filings, Genentech, Inc. sponsors H-1B workers regularly and likely has experience navigating the visa process. The most commonly sponsored position is Molecular and Cellular Biologists, representing 5 of the total filings.

How to Apply

To pursue H-1B sponsorship at Genentech, Inc., consider these steps based on their sponsorship profile:

Frequently Asked Questions

Does Genentech, Inc. sponsor H-1B visas?
Yes. Genentech, Inc. filed 32 H-1B labor condition applications in the FY2026 Q1 period, with a 90.6% certification rate. This data is from U.S. Department of Labor records.
What is Genentech, Inc.'s H-1B approval rate?
Genentech, Inc. has a 90.6% H-1B approval rate based on the most recent Department of Labor filings. Out of 32 petitions, 29 were certified.
What salary does Genentech, Inc. offer for H-1B positions?
The median salary for H-1B positions at Genentech, Inc. is $126,942, with a range from $116,376 (25th percentile) to $161,637 (75th percentile). These figures represent base salary from government filings and do not include equity or bonuses.

Similar H-1B Sponsors in California

Data from U.S. Department of Labor, FY2026 Q1 LCA Disclosure. Updated quarterly.